NEETPGAI
BlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Subjects
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Help Center

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/PSM/Cardiovascular Disease Epidemiology
    Cardiovascular Disease Epidemiology
    medium
    users PSM

    A 52-year-old male from rural Maharashtra with no prior medical history presents to a primary health centre with chest discomfort for 2 hours. He is conscious, BP 145/92 mmHg, HR 88/min, RR 18/min. No dyspnoea. Physical examination is unremarkable. The health worker performs a 12-lead ECG which shows ST elevation in leads II, III, aVF. The nearest PCI-capable centre is 120 km away (3–4 hours by road). What is the most appropriate immediate next step?

    A. Observe for 6 hours and repeat ECG; if ST elevation persists, then refer
    B. Administer aspirin 300 mg, clopidogrel 600 mg, and arrange immediate transfer to PCI centre
    C. Administer aspirin 300 mg and start intravenous streptokinase 1.5 million units over 60 minutes at the PHC
    D. Administer only aspirin 300 mg and refer after stabilisation

    Explanation

    ## Clinical Context This is an acute STEMI (inferior wall) in a resource-limited setting with significant distance from a PCI centre. The time-to-PCI exceeds the 120-minute window, making fibrinolytic therapy the guideline-recommended reperfusion strategy. ## Key Point: **In India, when PCI-capable centre is >120 minutes away, fibrinolytic therapy (streptokinase or tenecteplase) should be administered immediately at the point of first medical contact (PFMC), even in a PHC.** This is endorsed by the Indian College of Cardiology and ACC/AHA guidelines for STEMI management in resource-limited settings. ## Rationale for Correct Answer 1. **Dual antiplatelet therapy (aspirin + clopidogrel)** is given to all STEMI patients regardless of reperfusion strategy. 2. **Streptokinase 1.5 million units IV over 60 minutes** is the fibrinolytic agent of choice in India due to cost-effectiveness and availability. 3. **Time is myocardium:** Door-to-needle time for fibrinolysis should be <30 minutes. Delaying for transfer (3–4 hours) would result in myocardial loss. 4. **Contraindications to fibrinolysis** (absolute: active bleeding, recent surgery, intracranial pathology; relative: uncontrolled hypertension, recent trauma) are absent in this patient. ## High-Yield: **Fibrinolytic therapy reduces mortality by ~25% when given within 12 hours of symptom onset; benefit is greatest within 3 hours. In rural India, PHC-level thrombolysis saves more lives than delayed PCI.** ## Clinical Pearl: After fibrinolysis, if reperfusion is achieved (chest pain relief, ST resolution, arrhythmia cessation), the patient should still be transferred to a PCI centre for coronary angiography within 24 hours (rescue PCI if fibrinolysis fails, or elective angiography if successful). ## Comparison Table: Reperfusion Strategy Selection | Factor | PCI | Fibrinolysis | | --- | --- | --- | | **Time-to-reperfusion** | <90 min from PFMC | <30 min from PFMC | | **Mortality reduction** | 25–30% | 25% | | **Reinfarction rate** | Lower | Higher | | **Intracranial haemorrhage** | Rare | 0.5–0.9% | | **Suitable when PCI >120 min away** | No | Yes | | **Resource requirement** | Cathlab, trained team | Drugs, IV access | [cite:ACC/AHA STEMI Guidelines 2013, Indian College of Cardiology Consensus] ![Cardiovascular Disease Epidemiology diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/15784.webp)

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More PSM Questions